cilostazol and substance p

cilostazol has been researched along with substance p in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arakawa, H; Kuroume, T; Morikawa, A; Tokuyama, K; Yokoyama, T	1
Ohrui, T	1
Hibi, S; Ishii, M; Kume, H; Ouchi, Y; Teramoto, S; Yamaguchi, Y; Yamamoto, H	1
Hattori, N; Miyamoto, N; Mochizuki, H; Tanaka, R; Urabe, T; Zhang, N	1
Abe, A; Hagiwara, H; Katayama, Y; Katsura, K; Nishiyama, Y; Okubo, S; Ueda, M	1

Reviews

1 review(s) available for cilostazol and substance p

Article	Year
Preventive strategies for aspiration pneumonia in elderly disabled persons. The Tohoku journal of experimental medicine, 2005, Volume: 207, Issue:1 Topics: Amantadine; Angiotensin-Converting Enzyme Inhibitors; BCG Vaccine; Capsaicin; Cilostazol; Deglutition; Disabled Persons; Dopamine; Folic Acid; Glossopharyngeal Nerve; Hand Disinfection; Humans; Influenza Vaccines; Pneumonia, Aspiration; Pneumonia, Bacterial; Posture; Substance P; Tetrazoles	2005

Article

Year

Preventive strategies for aspiration pneumonia in elderly disabled persons.

The Tohoku journal of experimental medicine, 2005, Volume: 207, Issue:1

Topics: Amantadine; Angiotensin-Converting Enzyme Inhibitors; BCG Vaccine; Capsaicin; Cilostazol; Deglutition; Disabled Persons; Dopamine; Folic Acid; Glossopharyngeal Nerve; Hand Disinfection; Humans; Influenza Vaccines; Pneumonia, Aspiration; Pneumonia, Bacterial; Posture; Substance P; Tetrazoles

2005

Trials

2 trial(s) available for cilostazol and substance p

Article	Year
Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke. Journal of the American Geriatrics Society, 2008, Volume: 56, Issue:6 Topics: Aged; Aspirin; Cilostazol; Cross-Over Studies; Deglutition Disorders; Double-Blind Method; Humans; Male; Phosphodiesterase Inhibitors; Saliva; Stroke; Substance P; Tetrazoles	2008
Administration of cilostazol, an antiplatelet, to patients with acute-stage cerebral infarction and its effects on plasma substance P level and latent time of swallowing reflex. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2013, Volume: 80, Issue:1 Topics: Acute Disease; Aged; Aged, 80 and over; Cerebral Infarction; Cilostazol; Deglutition; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Reflex; Substance P; Tetrazoles; Time Factors; Treatment Outcome	2013

Article

Year

Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke.

Journal of the American Geriatrics Society, 2008, Volume: 56, Issue:6

Topics: Aged; Aspirin; Cilostazol; Cross-Over Studies; Deglutition Disorders; Double-Blind Method; Humans; Male; Phosphodiesterase Inhibitors; Saliva; Stroke; Substance P; Tetrazoles

2008

Administration of cilostazol, an antiplatelet, to patients with acute-stage cerebral infarction and its effects on plasma substance P level and latent time of swallowing reflex.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2013, Volume: 80, Issue:1

Topics: Acute Disease; Aged; Aged, 80 and over; Cerebral Infarction; Cilostazol; Deglutition; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Reflex; Substance P; Tetrazoles; Time Factors; Treatment Outcome

2013

Other Studies

2 other study(ies) available for cilostazol and substance p

Article	Year
Effects of cilostazol, a cyclic nucleotide phosphodiesterase III inhibitor, on substance P-induced airflow obstruction and airway microvascular leakage in guinea pigs. Pharmacology, 1994, Volume: 48, Issue:5 Topics: Airway Obstruction; Airway Resistance; Animals; Asthma; Blood Pressure; Capillary Permeability; Cilostazol; Guinea Pigs; Injections, Intravenous; Lung; Male; Phosphodiesterase Inhibitors; Substance P; Tetrazoles	1994
Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model. Neuroscience, 2009, Jan-23, Volume: 158, Issue:2 Topics: Animals; Bacteria; Carotid Stenosis; Chronic Disease; Cilostazol; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Deglutition; Disease Models, Animal; Dopamine; Enzyme Activation; Fibrinolytic Agents; Gene Expression Regulation; Ligation; Male; Pneumonia; Rats; Rats, Wistar; Regional Blood Flow; Substance P; Substantia Nigra; Tetrazoles; Time Factors; Tyrosine 3-Monooxygenase	2009

Article

Year

Effects of cilostazol, a cyclic nucleotide phosphodiesterase III inhibitor, on substance P-induced airflow obstruction and airway microvascular leakage in guinea pigs.

Pharmacology, 1994, Volume: 48, Issue:5

Topics: Airway Obstruction; Airway Resistance; Animals; Asthma; Blood Pressure; Capillary Permeability; Cilostazol; Guinea Pigs; Injections, Intravenous; Lung; Male; Phosphodiesterase Inhibitors; Substance P; Tetrazoles

1994

Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model.

Neuroscience, 2009, Jan-23, Volume: 158, Issue:2

Topics: Animals; Bacteria; Carotid Stenosis; Chronic Disease; Cilostazol; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Deglutition; Disease Models, Animal; Dopamine; Enzyme Activation; Fibrinolytic Agents; Gene Expression Regulation; Ligation; Male; Pneumonia; Rats; Rats, Wistar; Regional Blood Flow; Substance P; Substantia Nigra; Tetrazoles; Time Factors; Tyrosine 3-Monooxygenase

2009